RESEARCHER PROFILE

Frank P. McCormick

← Back to University of California, San Francisco

F

University of California, San Francisco

Protein Kinase Regulation and GTPase SignalingProtein Tyrosine PhosphatasesMelanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancerCellular transport and secretion

Frank P. McCormick works in Protein Kinase Regulation and GTPase Signaling, Protein Tyrosine Phosphatases, Melanoma and MAPK Pathways, PI3K/AKT/mTOR signaling in cancer, Cellular transport and secretion. Recorded institutional associations include University of California, San Francisco, Frederick National Laboratory for Cancer Research, National Cancer Institute.

825Publications
79,736Citations
127H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

    1999 · 3,601 citations
  2. The GTPase superfamily: conserved structure and molecular mechanism

    1991 · 3,386 citations
  3. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

    2006 · 3,188 citations
  4. Oncogenic Signaling Pathways in The Cancer Genome Atlas

    2018 · 3,175 citations
  5. The GTPase superfamily: a conserved switch for diverse cell functions

    1990 · 2,333 citations
  6. RAS Proteins and Their Regulators in Human Disease

    2017 · 1,904 citations
  7. Proteins regulating Ras and its relatives

    1993 · 1,901 citations
  8. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

    2017 · 1,767 citations
  9. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

    1996 · 1,760 citations
  10. The RB and p53 pathways in cancer

    2002 · 1,687 citations
  11. A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants

    1987 · 1,208 citations
  12. Dual Role of Phosphatidylinositol-3,4,5-trisphosphate in the Activation of Protein Kinase B

    1997 · 1,201 citations
  13. RAS-targeted therapies: is the undruggable drugged?

    2020 · 1,077 citations
  14. Protein Kinase B Kinases That Mediate Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Activation of Protein Kinase B

    1998 · 1,059 citations
  15. Two G Protein Oncogenes in Human Endocrine Tumors

    1990 · 1,037 citations
  16. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21

    1990 · 982 citations
  17. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

    1997 · 940 citations
  18. Inhibition by cAMP of Ras-Dependent Activation of Raf

    1993 · 922 citations
  19. An essential role for Rac in Ras transformation

    1995 · 882 citations
  20. Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization

    1996 · 838 citations
  21. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

    2014 · 833 citations
  22. Chromosome aberrations in solid tumors

    2003 · 811 citations
  23. Dragging Ras Back in the Ring

    2014 · 788 citations
  24. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases

    1990 · 746 citations
  25. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

    1988 · 709 citations

← Return to the university profile